Trials / Withdrawn
WithdrawnNCT00855127
New Urine and Blood Markers for Acute Kidney Injury in Liver Transplant Patients
Early Biomarkers of Acute Kidney Injury in Liver Transplant Patients
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find new blood and urine tests that detect acute kidney injury earlier than our current blood tests in patients receiving a liver transplant.
Detailed description
Patients with end stage liver disease that receive a liver transplant will be studied to determine if novel serum and urine biomarkers (serum cystatin C, urine interleukin-18 \[IL-18\] and urine neutrophil gelatinase associated lipocalin \[NGAL\]) can predict the outcome measures listed above.
Conditions
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2013-06-01
- Completion
- 2013-07-01
- First posted
- 2009-03-04
- Last updated
- 2015-06-01
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00855127. Inclusion in this directory is not an endorsement.